Observational studyDigestive diseases and sciences2019

Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.

Kindra Dawn Clark-Snustad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.